Pandemic influenza vaccine H5N1 AstraZeneca
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pandemic influenza vaccine H5N1 AstraZeneca, covering 2025-12-10 to 2025-12-10. Get the full timeline:
Most recent: EMA Authorised: Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune) (reassortant influenza virus (live attenuated) of the following strain: A/Vietnam/1203/2004 (H5N1) strain) — AstraZeneca AB